URGN — UroGen Pharma Ltd. stock price, charts and financials

QT73UroGen Pharma Ltd.

UroGen Pharma Ltd. (NASDAQ: URGN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
43.25
-0.70-1.59%
OverviewShort InterestFilings
URGNQT73UroGen Pharma Ltd.·NASDAQ
43.25-1.59%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 09, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Aug 28, 20264Statement of changes in beneficial ownership
Aug 24, 20264Statement of changes in beneficial ownership
Aug 20, 20268-KCurrent report
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Jul 10, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
Jun 02, 20268-KCurrent report
May 27, 2026ARSAnnual report to shareholders
May 27, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 11, 20264Statement of changes in beneficial ownership
May 06, 20268-KCurrent report
#1 / 25 of 304
Page
▼
/ 13